Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Solasodine is a steroidal alkaloid found in plants of the family Solanaceae, such as potatoes and tomatoes. It is the aglycone component of glycoalkaloids like solamargine and solasonine. While itself toxic at high doses, it has been studied for a range of pharmacological activities including anticancer, diuretic, antifungal, cardiotonic, antispermatogenetic, antiandrogenic, immunomodulatory, antipyretic and central nervous system effects[1][3]. Preclinical studies show that solasodine inhibits proliferation and invasion of various cancer cell lines (including colon, liver, breast—especially HER2-overexpressing—and lung cancers), possibly by downregulating matrix metalloproteinases (MMPs) involved in tumor invasion[1][7][8]. It also exhibits CNS activity (antipyretic/anticonvulsant/memory enhancing), diuretic effects, hepatoprotective properties and more[1][3]. Commercially it is used as a precursor for synthesis of steroidal drugs such as corticosteroids and contraceptives[4]. Its mechanism in cancer appears to involve inhibition of cell proliferation/migration/invasion via modulation of MMPs and stemness markers; however its precise molecular targets are not fully defined[7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on solasodine.